{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "PILA PHARMA AB", "longName": "Pila Pharma AB (publ)", "messageBoardId": "finmb_329992468", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 18.61703, "regularMarketPrice": 0.223, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1628143200000, "priceHint": 4, "epsTrailingTwelveMonths": -0.0, "sharesOutstanding": 18407400, "bookValue": 0.145, "fiftyDayAverage": 0.20706, "fiftyDayAverageChange": 0.01594001, "fiftyDayAverageChangePercent": 0.07698257, "twoHundredDayAverage": 0.2791, "twoHundredDayAverageChange": -0.056099996, "twoHundredDayAverageChangePercent": -0.20100321, "marketCap": 5403602, "priceToBook": 1.5379311, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.03500001, "regularMarketTime": 1683875702, "regularMarketDayHigh": 0.223, "regularMarketDayRange": "0.223 - 0.223", "regularMarketDayLow": 0.223, "regularMarketVolume": 100, "regularMarketPreviousClose": 0.188, "bid": 0.235, "ask": 0.0, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.223, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.052, "fiftyTwoWeekLowChangePercent": 0.30409357, "fiftyTwoWeekRange": "0.171 - 0.502", "fiftyTwoWeekHighChange": -0.27899998, "fiftyTwoWeekHighChangePercent": -0.5557769, "fiftyTwoWeekLow": 0.171, "fiftyTwoWeekHigh": 0.502, "earningsTimestamp": 1628625600, "earningsTimestampStart": 1652704200, "earningsTimestampEnd": 1653049800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "5KC.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Norra Vallgatan 72", "city": "Malm\u00f6", "zip": "211 22", "country": "Sweden", "phone": "46 7 39 03 69 69", "website": "https://pilapharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2b clinical trials for type 2 diabetes. The company was incorporated in 2014 and is based in Malm\u00f6, Sweden.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Ms. Dorte Xenia Gram", "age": 53, "title": "Founder, CEO & Director", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Elna Lembrer Astrom", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Miguel  Lecumberri", "title": "Head of Compliance & Legal Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gustav Hanghoj Gram", "title": "Head of Office", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Masoud  Alavi", "title": "Head of Corp. Visual Communication", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andy  Makin", "title": "Head of Toxicology", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Maura  McArdle", "title": "Head of BD & Quay Pharma", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mike  Frodsham", "title": "CTO of Quay Pharma", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Alison  Foster", "title": "Head of Pre-Clinical - Quay Pharma", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Simon  Hamilton", "title": "Head of Global Bus. Devel. - Almac", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}